Delcath Systems, Inc. (DCTH): Price and Financial Metrics

Delcath Systems, Inc. (DCTH): $9.63

0.28 (-2.83%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

DCTH Price/Volume Stats

Current price $9.63 52-week high $12.88
Prev. close $9.91 52-week low $2.60
Day low $9.50 Volume 397,900
Day high $10.04 Avg. volume 278,427
50-day MA $9.68 Dividend yield N/A
200-day MA $7.38 Market Cap 307.91M

DCTH Stock Price Chart Interactive Chart >


Delcath Systems, Inc. (DCTH) Company Bio


Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company's lead product candidate is the melphalan hydrochloride for injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. Its Phase III clinical trial products include FOCUS Trial for the patients with hepatic dominant ocular melanoma; and ALIGN Trial for intrahepatic cholangiocarcinoma. The company also offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York.


DCTH Latest News Stream


Event/Time News Detail
Loading, please wait...

DCTH Latest Social Stream


Loading social stream, please wait...

View Full DCTH Social Stream

DCTH Price Returns

1-mo -15.30%
3-mo 20.22%
6-mo 23.78%
1-year 233.22%
3-year 1.37%
5-year -68.66%
YTD 131.49%
2023 15.56%
2022 -53.55%
2021 -56.75%
2020 -15.67%
2019 -89.16%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!